Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pericystic brain transcriptomics reveals molecular signatures of immune activation and neurovascular remodelling in viable and post-treatment porcine neurocysticercosis.

bioRxiv : the preprint server for biology·2026
Same author

Interictal epileptiform discharges in calcified neurocysticercosis-associated epilepsy: An exploratory study.

Epilepsia·2026
Same author

Monoclonal antibody-based immunohistochemistry reveals residual Taenia solium antigens in calcified granulomas from pigs with neurocysticercosis.

PLoS neglected tropical diseases·2026
Same author

Integrating age-dependent pig susceptibility and spatial exposure heterogeneity improves agent-based modeling of Taenia solium transmission.

International journal for parasitology·2026
Same author

Updates on diagnosis and management of parasitic infections of the central nervous system.

Current opinion in infectious diseases·2026
Same author

Taenia solium neurocysticercosis: Its current epidemiological, diagnostic, therapeutic, and control landscapes.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: Jul 16, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Taenia solium cysticercosis.

Héctor H García1, Armando E Gonzalez, Carlton A W Evans

  • 1Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Jr Ancash 1271, Barrios Altos, Lima, Peru. hgarcia@terra.com.pe

Lancet (London, England)
|August 23, 2003
PubMed
Summary

Neurocysticercosis, caused by the pork tapeworm (Taenia solium) larvae, is a significant cause of epilepsy worldwide. Control efforts focus on antiparasitic treatments and vaccine development.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jul 16, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Area of Science:

  • * Infectious Diseases
  • * Neuroparasitology
  • * Public Health

Background:

  • * Neurocysticercosis is a parasitic infection of the human nervous system caused by the larval stage of Taenia solium.
  • * It is a major cause of epilepsy in developing nations and is emerging in developed countries due to migration.
  • * Limited data exists on the natural history of Taenia solium taeniasis and cysticercosis.

Purpose of the Study:

  • * To review the current understanding of neurocysticercosis, its impact, and control strategies.
  • * To highlight the challenges in managing this neglected tropical disease.

Main Methods:

  • * Literature review of existing studies on Taenia solium epidemiology, clinical manifestations, and treatment.
  • * Analysis of current public health interventions and control measures.

Main Results:

  • * Neurocysticercosis remains a significant neurological burden, particularly epilepsy, in endemic regions.
  • * Treatment options are limited and often focus on symptom management, with antiparasitic drug use being controversial.
  • * Global immigration patterns are increasing the prevalence in non-endemic areas.

Conclusions:

  • * Effective control requires integrated strategies, including antiparasitic treatment of human populations and vaccine development for pigs.
  • * Further research into the natural evolution of the disease is needed.
  • * Public health awareness and improved diagnostics are crucial for disease elimination efforts.